AbbVie
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
AbbVie (ABBV) SEC Filings
Browse all AbbVie SEC filings, including Annual reports (10-K), Quarterly reports (10-Q), 8-K, proxy statements (DEF 14A), and insider filings (Form 4). Access official documents by filing date, reporting period, and form type. ...more
AbbVie Reports: Annual 10-K, Quarterly 10-Q & SEC Filings
SEC Filings
Date
2026
FWP
Free writing prospectus related to a securities offering
424B5
Shelf offering prospectus with final pricing terms
8-K
Material company events (earnings, M&A, or leadership changes)
FWP
Free writing prospectus related to a securities offering
424B5
Shelf offering prospectus with final pricing terms
4
Insider ownership (buying, selling) activity
10-K
Annual financial results and management updates
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
8-K
Material company events (earnings, M&A, or leadership changes)
8-K
Material company events (earnings, M&A, or leadership changes)
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
2025
10-Q
Quarterly financial results and management updates
8-K
Material company events (earnings, M&A, or leadership changes)
8-K
Material company events (earnings, M&A, or leadership changes)
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
8-K
Material company events (earnings, M&A, or leadership changes)
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
10-Q
Quarterly financial results and management updates
8-K
Material company events (earnings, M&A, or leadership changes)
3/A
Corrected or updated initial insider ownership
3
Initial disclosure of insider ownership
SC 13G/A
Updated passive ownership disclosure
8-K
Material company events (earnings, M&A, or leadership changes)
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
11-K
Annual performance report of employee stock plans
SD
Specialized disclosure report (e.g., conflict minerals)
AbbVie (Form FWP) 2026
Stock Offerings / Free writing prospectus related to a securities offering
Feb 26, 2026
